Explore Watchlists Pricing

Cyclo Therapeutics, Inc. (CYTH) Income statement

Market cap

$20.73M

P/E ratio

Summary Financials

Income statement Balance sheet Cash flow Other

	2011/12	2012/12	2013/12	2014/12	2015/12	2016/12	2017/12	2018/12	2019/12	2020/12	2021/12	2022/12	2023/12
Revenue	1	1	2	2	950,455	2	1,237,756	1,011,477	1,007,198	903,376	1,585,756	1,375,760	1
Revenue growth (%)	-
Cost of revenue	273,756	139,676	426,022	272,641	124,425	198,429	132,918	105,026	-	-	-	-	-
Gross profit	-	-	-	-	-	-	-	-	-	-	-	-	992,038
Gross margin (%)	-	-	-	-	-	-	-	-	-	-	-	-
Research & development	-	-	-	94,133	658,505	2	2,292,892	2,711,275	4,869,160	6,096,445	9,153,780	8,999,543	14
Operating margin (%)
Operating expenses	1	887,451	1	2	3	6	5,081,077	5,278,283	8,551,758	9,864,781	15,875,816	16,997,646	21
Operating income	-74,258	157,490	336,645	-562,314	-2,406,750	-4,205,887	-3,843,321	-4,266,806	-7,544,560	-8,961,405	-14,290,060	-15,621,886	-20,050,057
Income before tax	-97,767	99,203	284,909	-592,687	-2,431,370	-4,223,841	-3,833,060	-4,255,033	-7,532,533	-8,941,603	-14,286,655	-15,450,888	-20,057,302
Pretax margin (%)	-9.5	9.5	16.8	-37.8	-255.8	-281	-309.7	-420.7	-747.9	-989.8	-900.9	-1,123.1	-1,863.4
Provision for income taxes	-	25,000	80,000	-	120,000	-	-	-	-	-	-	-	-
Effective tax rate (%)	-			-		-	-	-	-	-	-	-	-
Net income	-97,767	74,203	204,909	-592,687	-2,551,370	-4,223,841	-3,833,060	-4,255,033	-7,532,533	-8,941,603	-14,286,655	-15,450,888	-20,057,302
Net income margin (%)
Earnings per share	-	-	-	-	-	-	-	-	-	-	-	-1.83	-1.23
Diluted EPS	-	-	-	-	-	-	-	-	-	-	-	-1.83	-1.23
EBITDA		-	-	-	-	-	-	-	-
EBITDA margin (%)		-	-	-	-	-	-	-	-